Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?

Concentra (CON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research • Sep 15, 2026

Concentra Group Holdings Parent: Potential Beneficiary Of Increased Injuries From Data Center Capex

Concentra Group Holdings Parent, rated BUY, has surged 78% YTD, driven by market share gains and strong operating leverage. CON beat 2Q26 earnings estimates, with revenue up 10% YoY and adjusted EBITDA up 22.5%, aided by higher patient revenue per visit. Future growth may be propelled by additional state-level workers' compensation reimbursement increases and a robust M&A pipeline.

Seeking Alpha • Sep 16, 2026

Concentra Expands Florida Footprint with New Daytona Beach Medical Center

DAYTONA BEACH, Fla.--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine and workforce health services, today announced the opening of its newest Florida medical center and first location in Volusia County. The Daytona Beach medical center expands access to occupational health services for employers and employees throughout the Greater Daytona region. Daytona Beach sits at the intersection of two critical Florida transportation corridors and is emerging as a ce.

Business Wire • Sep 14, 2026

CON vs. MEDP: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Sep 11, 2026

Are You Looking for a Top Momentum Pick? Why Concentra Group (CON) is a Great Choice

Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • Sep 9, 2026

Concentra Appoints Tanner Newton Chief Financial Officer

DALLAS--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine and workforce health services, today announced that Tanner Newton, senior vice president of strategy and finance, has been appointed executive vice president and chief financial officer, effective Nov. 1, 2026. Newton will continue to report to Matt DiCanio, Concentra's president and chief financial officer, who will become president and chief executive officer on Nov. 1, 2026. Newton will lead Concent.

Business Wire • Sep 8, 2026

3 Stocks to Add to Your Portfolio After Recent Broker Rating Upgrades

Concentra Group, QuinStreet and Arrow Electronics pair broker rating upgrades with strong projected earnings growth, making them stocks to consider.

Zacks Investment Research • Sep 3, 2026

CON vs. MEDP: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Aug 26, 2026

Concentra Group (CON) is a Great Momentum Stock: Should You Buy?

Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • Aug 19, 2026

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

DALLAS--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer, effective Jan. 1, 2027. Returning to the organization where she previously served in physician leadership roles, including area medical director, Dr. Rosenthal will lead Concentra's national clinical strategy, physician leadership,.

Business Wire • Aug 18, 2026